Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Spondylitis, Ankylosing × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 2 Stroke 1 Spondylitis, Ankylosing 1 Pulmonary Disease, Chronic Obstructive 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Kidney Failure, Chronic 1 Diabetes Mellitus 1 Coronary Artery Disease 1 COVID-19 1

Interventions

tocilizumab 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209689 2013-01-17

A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy

Hoffmann-La Roche

Phase 3 Terminated

113 enrolled 7 charts

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡